Last reviewed: July 1, 2026
Last updated: July 1, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Wegovy, the prescription GLP-1 medication made by Novo Nordisk, has become synonymous with significant weight loss outcomes in recent years. The landmark STEP trials demonstrated that patients using semaglutide achieved average weight reductions of 15% to 22% of their starting body weight over one year, substantially outperforming diet and exercise alone. Understanding what realistic weight loss looks like on GLP-1 therapy—and how to access affordable, personalized semaglutide treatment—can help you make an informed decision about your weight management journey.
Average Weight Loss on Wegovy: Clinical Trial Results
The STEP 1 clinical trial, which enrolled nearly 2,000 adults with obesity or overweight with weight-related conditions, found that participants taking semaglutide 2.4 mg weekly lost an average of 14.9% of their body weight by week 68. In comparison, the placebo group lost only 2.4% of body weight. This difference—approximately 12.5 percentage points—represents one of the most significant weight loss medications studied in modern medicine. The trial continued for 120 weeks total, and results remained consistent throughout the observation period.
STEP 2 specifically examined semaglutide in patients with type 2 diabetes, showing an average weight loss of 9.6% for the 2.4 mg dose group. While this percentage appears lower, the absolute pounds lost were often substantial because participants typically started from higher baseline weights or had metabolic complications. STEP 3 and STEP 4 extended these findings to diverse populations and demonstrated sustained weight loss maintenance when patients continued their medication.
Why Individual Weight Loss Outcomes Vary on Semaglutide
Although average weight loss is measurable, individual results depend on several interconnected factors including baseline metabolic rate, genetics, meal timing, physical activity level, and medication adherence. Two people of the same age, sex, and starting weight may experience different weight loss trajectories because their bodies respond to GLP-1 signaling in unique ways. Genetic variants in the GLP-1 receptor gene (GLP1R rs6923761), the GIPR pathway (rs1800437), and energy regulation genes like FTO (rs9939609) influence how efficiently your system processes appetite signals and burns calories.
Dose titration also affects outcomes significantly. Wegovy requires a gradual 16-week dose escalation starting at 0.25 mg and building to the therapeutic 2.4 mg dose. Patients who tolerate higher doses and maintain consistent weekly injections typically see stronger results than those who delay escalation due to gastrointestinal side effects or remain on lower maintenance doses.
Compounded Semaglutide vs. Wegovy: Cost and Access Differences
Wegovy brand-name semaglutide typically costs $1,300 to $1,500 per month through insurance or pharmacy cash pricing, creating a significant barrier for many patients. PlexusDx offers compounded semaglutide injections—manufactured by licensed 503A compounding pharmacies and clinically equivalent to brand-name formulations—starting at just $149 per month. This pricing structure means the same active pharmaceutical ingredient reaches your body without the brand markup, and your dose may need to go up while your price stays flat across all three commitment tiers.
PlexusDx serves all 50 states without requiring insurance, membership fees, or lengthy prior authorizations. Treatment is HSA and FSA eligible, further reducing your out-of-pocket costs. The company's tiered monthly subscriptions offer flexibility: whether you commit to three months, six months, or an ongoing relationship with your prescriber, your cost per month remains consistent as you adjust your dose upward during titration and maintenance phases.
Personalized Weight Loss with PlexusDx Precision Genetic Testing
Beyond standard semaglutide injections, PlexusDx offers the Precision Peptide Genetic Test—a peptide-pathway analysis examining 14 metabolic pathways and 150+ genetic insights related to weight regulation and GLP-1 response. This $99 test (added after your first month of treatment) identifies your unique genetic predispositions in key variants including GLP1R, GIPR, FTO, and MC4R. Understanding these variants helps your PlexusDx provider optimize your specific dose, timing, and formulation to maximize your weight loss while minimizing side effects.
Rather than a one-size-fits-all approach, genetic-informed semaglutide therapy tailors your treatment plan to your body's peptide pathways. Patients with certain genetic profiles may respond better to higher doses, while others achieve excellent results at moderate doses with fewer gastrointestinal effects. This personalized strategy increases the likelihood that your actual weight loss aligns with or exceeds clinical trial averages, turning statistical data into your individual success story.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Will I lose as much weight as the clinical trial patients if I start Wegovy or semaglutide?
Clinical trial participants averaged 15% body weight loss, but your individual result depends on genetics, adherence, dose tolerance, and lifestyle factors. PlexusDx's Precision Peptide Genetic Test identifies your genetic predispositions in GLP-1 pathways, allowing your provider to personalize your semaglutide dose and protocol to optimize your specific outcome potential.
How much weight can I realistically expect to lose in the first month on semaglutide?
Most patients lose 2–4 pounds in the first month during dose escalation, with accelerated weight loss occurring weeks 4–8 as the dose increases. Full therapeutic benefits typically emerge by weeks 8–12 when you reach the maintenance dose. Individual variation is significant, and some people see delayed initial loss due to dose escalation pacing or medication tolerance.
Is compounded semaglutide from PlexusDx as effective as brand-name Wegovy?
Yes. PlexusDx's compounded semaglutide comes from licensed 503A compounding pharmacies and contains the identical active pharmaceutical ingredient as Wegovy at a fraction of the cost. Clinical efficacy is equivalent; the main difference is price—PlexusDx starts at $149/month with no your dose may need to go up - your price won't goes up.
Can I maintain weight loss after I stop semaglutide?
Clinical data shows that weight regain occurs in most patients who discontinue GLP-1 therapy, particularly if diet and exercise habits don't change significantly. Many patients choose ongoing semaglutide therapy at PlexusDx for sustained weight management. Your provider can discuss long-term treatment strategies tailored to your goals and genetic profile.
How does PlexusDx's genetic test help me lose more weight?
The Precision Peptide Genetic Test ($99 after first month) analyzes variants in GLP1R, GIPR, FTO, and MC4R genes across 14 metabolic pathways. This information helps your PlexusDx provider fine-tune your dose, injection timing, and formulation choice to match your genetics, increasing the likelihood that you'll see results aligning with or exceeding published trial averages.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
The Journey to Wellness: How Much Time Does It Take for Ozempic to Work?
What Happens When You Stop Taking Ozempic for Diabetes